CEO (Gene Therapy) - Remote from Europe

Advanced degree (PhD or MD) in Life Sciences, Biotechnology, Genetics, or a related field; business training (MBA or equivalent) is an advantage Proven experience in leading or scaling biotech or pharmaceutical ventures (ideally within RNA therapeutics, gene therapy, or rare disease) Demonstrated success in fundraising, including venture capital and strategic partnerships Proven track record in strategic transactions Track record of translating early-stage scientific innovation into clinical development Strong scientific understanding of delivery technologies such as AAV capsids or related gene therapies and RNA biology Familiarity with regulatory pathways, translational medicine, and early clinical development for rare diseases Entrepreneurial, hands-on, and comfortable operating in a dynamic, high-growth environment

Lead the company’s overall strategy, growth, and fundraising, securing seed and Series A investment Drive the scientific and clinical roadmap toward IND readiness for the CMT2D program while expanding the broader tRNA platform Build and inspire a multidisciplinary team Establish strong partnerships with investors, academic collaborators, pharmaceutical partners, and patient foundations Represent XtRNA Bio externally